Use of Temporary Membrane-Covered Self-Expandable Metallic Stent – UVENTATM for Treatment of Recurrent Bulbar Urethral Stricture
Ibrahim Alnadhari,Nabil N Moohialdin,Venkata Ramana Pai Sampige,Omar Ali,Osama Abdeljaleel,Morshed Salah,Omid Sedigh,Ahmad Shamsodini,Abdulla Al-Ansari,Venkata Ramana Pai Sampige,Abdulla A Al-Ansari
DOI: https://doi.org/10.2147/RRU.S363557
2022-05-13
Research and Reports in Urology
Abstract:Ibrahim Alnadhari, 1, 2 Nabil N Moohialdin, 1 Venkata Ramana Pai Sampige, 1 Omar Ali, 1, 2 Osama Abdeljaleel, 1, 2 Morshed Salah, 2– 4 Omid Sedigh, 5 Ahmad Shamsodini, 1, 2, 4 Abdulla Al-Ansari 4, 6 1 Urology Section, Department of Surgery, Al Wakra Hospital, Hamad Medical Corporation, Al Wakra, Qatar; 2 Department of Surgery, Qatar University, Doha, Qatar; 3 Urology Section, Surgery Department of Surgery, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar; 4 Department of Surgery, Weill Cornell Medicine, Doha, Qatar; 5 Urological Department, San Giovanni Battista Molinette Hospital, Turin, Italy; 6 Department of Urology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar Correspondence: Ibrahim Alnadhari, Urology Section, Department of Surgery, Al Wakra Hospital, Hamad Medical Corporation, Qatar, Tel +0097433403324, Email Introduction: Recurrent urethral stricture is a real challenge. Interestingly use of temporary double layered self-expanding nitinol urethral stent with polytetrafluoroethylene (PTFE) membrane coating (Uventa TM , Taewoong Medical, South Korea) has been recently reported with promising short-term results in recurrent urethral stricture. However most of the reported studies are published as abstracts of either case reports or case series of miniscule numbers. The aim of our study is to evaluate the outcome of this temporary urethral stent in patients with recurrent urethral stricture after urethroplasty as well as after multiple visual internal urethrotomy. Materials and Methods: In this retrospective study, 22 patients had placement of double-layered self-expanding stent with PTFE membrane coating (Uventa, Taewoong Medical) for recurrent bulbar strictures. The present study included cases between 2017 and 2020. The stricture in each patient were evaluated with Uroflowmetry and ascending urethrography. The data of demographic and clinical characteristics included age, aetiology, location and length of stricture, along with maximum urinary flow rate (Qmax), number of previous interventions, and stent-related complications. Results: The overall clinical success was achieved in 13/22 (59.1%) of patients at a median follow-up of 17 months (range 2– 44). The mean maximum urine flow rates were 7.07 ± 3.55mL/sec, 23.50 ± 10.41mL/sec, 21.41± 15.55 mL/sec, 14.88 ± 9.77 and 17.63 ± 12.28 mL/sec before, while stent in place, at 3 months, 6 months and 12 months after the procedure, respectively. Conclusion: In our study, the success rate of temporary urethral stent placement has remained at 59.1% at a median follow-up of 17 months. We conclude that further randomized controlled studies with long-term follow up are required to fully evaluate the outcome. Keywords: urethra, urethral stricture, recurrence, urethral stent Recurrent urethral stricture is a real challenge, especially after urethroplasty as well as after multiple visual internal urethrotomy. Treatment options for patients with recurrent urethral stricture depend on the primary management options including visual urethrotomy, urethral dilatation, or urethroplasty. The higher recurrent stricture rate denoting lower success rate has been reported in repetitive endoscopic interventions. 1,2 Reported long-term success rate of 55% to 60% after the first internal urethrotomy which deteriorates after repeated urethrotomy to 0–40% at 48 months after the second urethrotomy and 0 at 24 months after the third urethrotomy. 1 Although urethroplasty has a better success rate for management of recurrent urethral stricture, it still has the failure rate ranging from 12%, to 58% depending on the type of surgery and the surgeon experience with reported complication rate of 7% to 33%. 3 Endoscopic treatment for recurrent urethral stricture after urethroplasty has a recurrence rate from 10% to 50% depending on the type of previous surgery and prior endoscopic interventions. 4,5 The use of urethral metallic stents in the prevention of the recurrence and maintenance of patency of the urethra has been adopted by many surgeons because it is a minimally invasive technique. An ideal urethral stent should be self-expandable, non-migrating, easily inserted as well as removed and with no complications such as encrustation and mucosal ingrowth. The Stent designs varied in size, shape, and composition, number of layers and with incorporated special features of coating, anchors and thermodynamic function. All literature available regarding metallic urethral stents show them to be made of nickel-titan -Abstract Truncated-